title: Limited TCF7L2 expression in MS lesions.
abstract: Multiple sclerosis is the most frequent demyelinating disease in the human CNS characterized by inflammation, demyelination, relative axonal loss and gliosis. Remyelination occurs, but is frequently absent or restricted to a small remyelinated rim at the lesion border. Impaired differentiation of oligodendroglial precursor cells is one factor contributing to limited remyelination, especially in chronic MS. TCF7L2 is an oligodendroglial transcription factor regulating myelin gene expression during developmental myelination as well as remyelination. TCF7L2 binds to co-effectors such as β-catenin or histone deacetylases and thereby activates or inhibits the transcription of downstream genes involved in oligodendroglial differentiation. To determine whether TCF7L2 can be used as a marker for differentiating or myelinating oligodendrocytes, we analyzed the expression patterns of TCF7L2 during myelination and remyelination in human and murine CNS tissue samples. Here, we demonstrate that marked expression of TCF7L2 in oligodendrocytes is restricted to a well defined time period during developmental myelination in human and mouse CNS tissue samples. In demyelinating diseases, such as multiple sclerosis, TCF7L2 is reexpressed in oligodendrocytes in a subset of MS patients, but is also present in tissue samples from patients with non-demyelinating, inflammatory diseases. Furthermore, TCF7L2 expression was also detected in astrocytes. HDAC2, a potential binding partner of TCF7L2 that promotes oligodendroglial differentiation and myelination, is expressed in the majority of oligodendrocytes in controls and MS tissue samples. In summary, our data demonstrate that the expression of TCF7L2 in oligodendrocytes is limited to a certain differentiation stage; however the expression of TCF7L2 is neither restricted to the oligodendroglial lineage nor to (re-)myelinating conditions.
authors: Institute of Neuropathology, University Hospital Münster, Münster, Germany.
authors: Alexander
authors: A
authors: Lürbke
authors: Karin
authors: K
authors: Hagemeier
authors: Qiao-Ling
authors: QL
authors: Cui
authors: Imke
authors: I
authors: Metz
authors: Wolfgang
authors: W
authors: Brück
authors: Jack
authors: J
authors: Antel
authors: Tanja
authors: T
authors: Kuhlmann
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000818:Animals; D016022:Case-Control Studies; D002490:Central Nervous System / Q000378:metabolism / Q000473:pathology; D003711:Demyelinating Diseases / Q000378:metabolism / Q000473:pathology; D005260:Female; D056464:Histone Deacetylase 2 / Q000378:metabolism; D006801:Humans; D007249:Inflammation / Q000378:metabolism / Q000473:pathology; D008264:Macrophages / Q000378:metabolism; D008297:Male; D008810:Mice, Inbred C57BL; D017628:Microglia / Q000378:metabolism; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000378:metabolism* / Q000473:pathology; D009186:Myelin Sheath / Q000378:metabolism; D009836:Oligodendroglia / Q000378:metabolism; D013601:T-Lymphocytes / Q000378:metabolism; D058118:Transcription Factor 7-Like 2 Protein / Q000378:metabolism*; D055815:Young Adult
chemical_list: C544894:TCF7L2 protein, human; C544895:Tcf7l2 protein, mouse; D058118:Transcription Factor 7-Like 2 Protein; C533423:HDAC2 protein, human; D056464:Histone Deacetylase 2
references: Brain. 1997 Mar;120 ( Pt 3):393-9
references: 9126051
references: Brain. 2006 Dec;129(Pt 12):3165-72
references: 16921173
references: Nat Struct Mol Biol. 2005 Apr;12(4):364-71
references: 15768032
references: Curr Opin Neurol. 2003 Jun;16(3):267-73
references: 12858061
references: Neurobiol Dis. 2010 Feb;37(2):362-9
references: 19853662
references: N Engl J Med. 2002 Jan 17;346(3):165-73
references: 11796850
references: Ann Neurol. 1995 Nov;38(5):788-96
references: 7486871
references: J Neurosci. 2006 Feb 22;26(8):2157-66
references: 16495442
references: J Neurochem. 2008 Oct;107(1):1-19
references: 18643793
references: Mult Scler. 2010 Apr;16(4):406-11
references: 20215480
references: Proc Natl Acad Sci U S A. 2009 Apr 21;106(16):6832-6
references: 19342494
references: Prog Brain Res. 1998;117:233-47
references: 9932412
references: Nat Neurosci. 2011 Jun 26;14(8):1009-16
references: 21706018
references: Am J Pathol. 2004 Dec;165(6):2167-75
references: 15579458
references: Curr Opin Neurol. 1999 Jun;12(3):295-302
references: 10499174
references: Ann Neurol. 2008 Jan;63(1):61-71
references: 17918267
references: J Cell Sci. 2007 Feb 1;120(Pt 3):385-93
references: 17251379
references: Proc Natl Acad Sci U S A. 2000 Jul 18;97(15):8358-63
references: 10890911
references: Nat Genet. 2003 Mar;33(3):366-74
references: 12590258
references: N Engl J Med. 1998 Jan 29;338(5):278-85
references: 9445407
references: Dev Dyn. 2008 Nov;237(11):3324-31
references: 18924237
references: J Neuropathol Exp Neurol. 2007 Mar;66(3):238-46
references: 17356385
references: Genes Dev. 2009 Jul 1;23(13):1571-85
references: 19515974
references: Brain. 2008 Jul;131(Pt 7):1749-58
references: 18515322
references: Brain Pathol. 2001 Jan;11(1):107-16
references: 11145196
references: Nat Neurosci. 2009 Jul;12(7):829-38
references: 19503085
references: Neuropathol Appl Neurobiol. 2007 Jun;33(3):277-87
references: 17442065
references: J Virol. 2007 Jun;81(11):5864-71
references: 17392368
references: Brain Pathol. 2011 Jul;21(4):428-40
references: 21114565
references: Mol Cell Neurosci. 2009 Nov;42(3):255-65
references: 19619658
references: Glia. 2011 Apr;59(4):540-53
references: 21319221
references: Brain. 1998 Aug;121 ( Pt 8):1469-77
references: 9712009
references: Am J Pathol. 2000 Jul;157(1):267-76
references: 10880396
references: Brain. 2008 Jun;131(Pt 6):1464-77
references: 18490361
references: Nature. 2008 Feb 28;451(7182):1076-81
references: 18278032
references: Neurology. 2009 Jun 2;72(22):1914-21
references: 19487649
references: Trends Mol Med. 2003 Dec;9(12):535-41
references: 14659468